The Department of Defense (DoD) has named five DoD locations to participate in the Phase III trial evaluating the vaccine candidate under development by AstraZeneca for Operation Warp Speed (OWS), the department’s
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.